Abstract:The tumor microenvironment (TME), composed of a diverse array of cells, jointly participates in tumor formation and has attracted attention as a direct or indirect therapeutic target. Among the tumor-forming cells, cancer cells, cancer-associated fibroblast (CAF), and tumor-infiltrating lymphocytes (TILs) comprise major proportion and players in tumor biology. Therefore, an in vitro tumor model composed of at least above three major cellular players better mimics a patient's tumor. Here, we developed a patient-derived tumor model containing tumoroids, CAFs and TILs isolated from the patient's tumor tissue by using one-stop isolation culture system. Our one-stop culture system utilizes a Transwell-based method that concurrently segregates cancer cells, CAFs, and TILs based on distinct characteristics such as cell size, migration speed, and growth. Lung tumoroids, fibroblasts, and TILs segregated in Matrigel-coated upper Transwell chamber, Transwell pores and in the lower chamber, respectively. Lung tumoroids maintain the patient's lung cancer tissue characteristics and genetic features during extended in vitro cultivation. Fibroblasts extracted from the Transwell pores exhibit significant similarity to CAFs found in patient tissue. TILs in the lower part of the Transwell chamber closely resemble those found in the original cancer tissue analyzed by FACS. We have also refined the functionality of TILs through a two-week expansion process. Patients' tumor composed of 0.15 to 95.3 % of EpCAM positive tumor cells, 0.14 to 19.4 % of CD90 positive fibroblasts and 3.98 to 91.2 % of immune cells in FACS analysis. By reassembling three main cellular components of the tumor in a proper proportion, we developed a co-culture platform for a patient-derived tumor model reproducing patient-specific TME conditions. The co-culture platform showed a potential not only for an experimental model but also to use a predictive test of personalized immunotherapy responses for lung cancer patients. Citation Format: YOO RI KO, Sung Min Kim, Hye Seon Park, Se Jin Jang. A comprehensive in vitro tumor model: One-stop simultaneous isolation and culture of tumoroids, CAFs and TILs for advancing immuno-oncology research [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4240.

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments

Establishment of Patient-Derived Tumor Spheroids for Non-Small Cell Lung Cancer

Lung cancer organoids: models for preclinical research and precision medicine

Patient-Derived Lung Cancer "Sandwich Cultures" with a Preserved Tumor Microenvironment

Highly Mimetic Ex Vivo Lung‐Cancer Spheroid‐Based Physiological Model for Clinical Precision Therapeutics (Adv. Sci. 16/2023)

Patient-Derived Tumor Organoid and Fibroblast Assembloid Models for interrogation of the tumor microenvironment in Esophageal Adenocarcinoma

Gastric Cancer Assembloids Derived from Patient-Derived Xenografts: A Preclinical Model for Therapeutic Drug Screening

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression.

Lung cancer organoids, a promising model still with long way to go

Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening

Abstract 4240: A comprehensive i n vitro tumor model: One-stop simultaneous isolation and culture of tumoroids, CAFs and TILs for advancing immuno-oncology research

A novel tissue-engineered 3D tumor model for anti-cancer drug discovery.

Embedded 3D printing of engineered lung cancer model for assisting fine-needle aspiration biopsy

[Application and Research Progress of Lung Cancer Organoid in Precision Medicine for Lung Cancer]

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening

Construction of 3D Tumor in Vitro Models with an Immune Microenvironment Exhibiting Similar Tumor Properties and Biomimetic Physiological Functionality.

Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer

Abstract 4261: Novel Tumor Microenvironment (TME) Restored 3D Cell Culture Model and Humanized Patient-Derived Xenograft Model for Cancer Research and Drug Evaluation

Polyurethane Scaffold-Based 3D Lung Cancer Model Recapitulates in Vivo Tumor Biological Behavior for Nanoparticulate Drug Screening.

3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation

Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer